Table 2. Overview of clinical datasets employed in this study.
Clinical Variables | Cohort A (20) | Cohort B (20) | Combined Cohort (40) | |
Pathological Gleason Score | 3+3 | 4 (20%) | 1 (5%) | 5 (12.5%) |
3+4 | 7 (35%) | 17 (85%) | 24 (60%) | |
4+3 | 7 (35%) | 2 (10%) | 9 (22.5%) | |
3+5 | 1 (5%) | - (-) | 1 (2.5%) | |
4+4 | 1 (5%) | - (-) | 1 (2.5%) | |
Pathologic Stage | pT2 | 8 (40%) | 12 (60%) | 20 (50%) |
pT3a | 9 (45%) | 6 (30%) | 15 (37.5%) | |
pT3b | 3 (15%) | 2 (10%) | 5 (12.5%) |